A carregar...
Prognostic Biomarkers for Response to VEGF Targeted Therapy for Renal Cell Carcinoma
Our improved understanding of renal carcinoma disease biology over the past three decades has led to the discovery and FDA-approval of five novel therapies targeting specific molecules in the VEGF biochemical pathway. In order to properly select patients who will receive maximal therapeutic benefit...
Na minha lista:
| Publicado no: | Urol Clin North Am |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4864362/ https://ncbi.nlm.nih.gov/pubmed/26614032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ucl.2015.08.009 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|